Intra-Cellular Therapies

FDA cancels panel review of Intra-Cellular’s schizophrenia drug, causing shares to tumble
FDA cancels panel review of Intra-Cellular’s schizophrenia drug, causing shares to tumble
Stat
Intra-Cellular Therapies
FDA
advisory panels
schizophrenia
lumateperone
Flag link:
Intra-Cellular optimistic on lumateperone's future in bipolar despite mixed Phase III results
Intra-Cellular optimistic on lumateperone's future in bipolar despite mixed Phase III results
BioCentury
Intra-Cellular Therapies
lumateperone
clinical trials
bipolar disorder
Flag link:
FDA Clears Way for Filing on Psych Drug From Intra-Cellular, Shares Climb
FDA Clears Way for Filing on Psych Drug From Intra-Cellular, Shares Climb
Xconomy
FDA
Intra-Cellular Therapies
lumateperone
schizophrenia
Flag link:
The 'Gnarly 9' Biotechs Will Test the FDA's Mettle
The 'Gnarly 9' Biotechs Will Test the FDA's Mettle
TheStreet.com
FDA
drug approvals
Alkermes
ALKS-5461
CytRx
aldoxorubicin
Dynavax Technologies
HEPLISAV-B
Intra-Cellular Therapies
ITI-007
Novan
SB204
Portola Pharmaceuticals
betrixaban
PTC Therapeutics
ataluren
Rigel Pharmaceuticals
fostamatinib
TG Therapeutics
ublituximab
Flag link:
3 Biotech Companies With Recent Large Insider Buying
3 Biotech Companies With Recent Large Insider Buying
Yahoo/Benzinga
biotech
OPKO Health
Seattle Genetics
Intra-Cellular Therapies
Flag link:
3 Biotech Stocks With 2016 Phase 3 Data That Could Have Huge Upside Potential
3 Biotech Stocks With 2016 Phase 3 Data That Could Have Huge Upside Potential
24/7 Wall St
biotech
Aerie Pharma
Rhopressa
ITI-007
Intra-Cellular Therapies
Flag link:
9 Biotech Picks for 2016
9 Biotech Picks for 2016
Barron's
biotech
Adaptimmune
Dermira
FibroGen
Incyte
Intra-Cellular Therapies
Seres Therapeutics
Ophthotech
Neurocrine Biosciences
Paratek
Flag link:
3 Rising Biotechs That Should Continue Their Upward Trends
3 Rising Biotechs That Should Continue Their Upward Trends
TheStreet.com
biotech
Intra-Cellular Therapies
Anacor
Prothena
Flag link:
These Drugs Could Deliver $5 Billion (or More) in Annual Sales
These Drugs Could Deliver $5 Billion (or More) in Annual Sales
Motley Fool
Receptos
Celgene
ozanimod
Novo Nordisk
Intra-Cellular Therapies
ITI-007
Flag link:
Top 6 Biotech Movers From The Past Week
Top 6 Biotech Movers From The Past Week
24/7 Wall St
Aerie Pharma
Can-Fite BioPharma
Intra-Cellular Therapies
Raptor Pharmaceuticals
TRACON Pharmaceuticals
XenoPort
Flag link:
4 Biotech and Pharma Stocks Projected to Rise 50% to 100%
4 Biotech and Pharma Stocks Projected to Rise 50% to 100%
24/7 Wall St
Flex Pharma
Intercept Pharmaceuticals
Intra-Cellular Therapies
SteadyMed
Flag link:
Intra-Cellular reports 4Q loss
Intra-Cellular reports 4Q loss
Yahoo/AP
Intra-Cellular Therapies
earnings
Flag link:
Intra-Cellular posts 3Q loss
Intra-Cellular posts 3Q loss
Yahoo/AP
Intra-Cellular Therapies
earnings
Flag link:
Why the Earnings Streak Will Continue for Intra-Cellular (ITCI)
Why the Earnings Streak Will Continue for Intra-Cellular (ITCI)
Yahoo/Zacks.com
earnings
Intra-Cellular Therapies
Flag link:
Takeda Enters Schizophrenia Partnership: Biotech's Latest Deals
Takeda Enters Schizophrenia Partnership: Biotech's Latest Deals
Seeking Alpha
Takeda
Intra-Cellular Therapies
schizophrenia
Flag link: